Following exposure to estrogen, a low dose of NO-donor represses apoptosis, while higher NO concentrations induce mixed effects on hormone treated BC phenotype; reduced proliferation and metabolic activity, as well as downregulation of survivin levels on the one hand, with inhibition of PS externalization on the other. The gene discussed is BIRC5; the disease is breast cancer.